| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,573,915 | 1,519,041 | 1,447,640 | 1,461,010 | | Cost of Revenue | 1,095,857 | 1,051,879 | 1,005,886 | 1,011,344 | | | Gross Profit | 478,058 | 467,162 | 441,754 | 449,666 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 134,931 | 132,166 | 127,273 | 133,659 | | Non Recurring | 119,990 | (18) | 18 | (98,066) | | Others | (21,156) | 99,418 | 93,859 | 202,473 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 245,359 | 235,596 | 220,604 | 211,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 999 | 49,574 | (47,547) | 2,080 | | Earnings Before Interest And Taxes | 246,000 | 285,528 | 173,057 | 213,680 | | Interest Expense | 45,535 | 95,389 |
-
| 55,825 | | Income Before Tax | 200,465 | 190,139 | 173,057 | 157,855 | | Income Tax Expense | 74,195 | 70,507 | 64,783 | 59,490 | | Minority Interest | (41,216) | 12,063 | (12,063) |
-
| | | | Net Income From Continuing Ops | 86,120 | 131,695 | 96,211 | 98,365 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 85,054 | 131,695 | 96,211 | 98,365 | | Preferred Stock And Other Adjustments | 25,876 | (25,876) |
-
|
-
| | | Net Income Applicable To Common Shares | $110,930 | $105,819 | $96,211 | $98,365 |
|
0.51% Nasdaq 0.00%
Income Statement
